Cargando…
Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care
INTRODUCTION: The utility of the Appropriate Use Criteria (AUC) for amyloid imaging is not established. METHODS: Fifty-three cognitively impaired patients with clinical F(18)-florbetapir imaging were classified as early and late onset, as well as AUC-consistent or AUC-inconsistent. Chi-square statis...
Autores principales: | Apostolova, Liana G., Haider, Janelle M., Goukasian, Naira, Rabinovici, Gil D., Chételat, Gael, Ringman, John M., Kremen, Sarah, Grill, Joshua D., Restrepo, Lucas, Mendez, Mario F., Silverman, Daniel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198877/ https://www.ncbi.nlm.nih.gov/pubmed/28054024 http://dx.doi.org/10.1016/j.dadm.2016.12.001 |
Ejemplares similares
-
The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism
por: Stage, Eddie, et al.
Publicado: (2016) -
Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging
por: La Joie, Renaud, et al.
Publicado: (2016) -
Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017) -
Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2020) -
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
por: Witte, Michael M., et al.
Publicado: (2015)